Country in Focus - Nigeria

With a population of about 186 million, Nigeria is the most populous country in Africa, and 100% of the population is at risk of malaria infection. Two countries, Nigeria and the Democratic Republic of Congo, account for over 35% of total estimated malaria deaths. The public health system in Nigeria is weak, particularly at the primary care level; it is estimated that the government spends less than 5% of the national budget on health.


Nigeria is currently in its sixth year as a PMI focus country. With support from PMI and its partners, malaria control interventions are being scaled up, and vital commodities are being distributed to vulnerable populations. The most recent national population-based survey measuring malaria program progress in Nigeria shows impressive results. From 2010-2015, overall ownership of at least one insecticide treated net (ITN) increased, with usage rates among children and pregnant women also showing significant increases. Other PMI supported activities include: continued vector and insecticide resistance monitoring; indoor residual spraying (IRS) advocacy and support training; piloting community focused antenatal care (ANC) programs with intermittent preventative treatment for pregnant women (IPTp) where ANC attendance is low; procurement of antenatal drugs for focused antenatal care clinics; and expanded provision of rapid diagnostic tests (RDTs) and artemisinin-based combination therapy (ACTs) to patent and proprietary medicine vendors to upgrade testing and treatment services in the private sector.